Crizalk Capsule (Crizotinib 250mg)

(1 customer review)

US$ 1,850US$ 7,402

US$ 1,850
($30.83 per respule)
US$ 3,516
($29.3 per respule)
US$ 4,996
($27.76 per respule)
US$ 6,291
($26.21 per respule)
US$ 7,402
($24.67 per respule)
Active ingredient

Strength

250mg

Dosage Form

Capsule

Indication

Non-small cell lung cancer

Manufacturer

Pfizer India Ltd

Packaging

60 capsules in 1 bottle

SKU: RM4092 Categories: , ,

Description

1 review for Crizalk Capsule (Crizotinib 250mg)

  1. Wowadoc

    It was the best

Add a review

Your email address will not be published. Required fields are marked *